MetaADEDB 2.0 @ LMMD
brivaracetam
(MSYKRHVOOPPJKU-BDAKNGLRSA-N)
Structure
SMILES
CCC[C@H]1CN(C(=O)C1)[C@H](C(=O)N)CC
Type(s)
Approved; Investigational
ATC code(s)
N03AX23
Molecular Formula:
C11H20N2O2
Molecular Weight:
212.289
Log P:
1.5371
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
63.4
CAS Number(s):
357336-20-0
Synonym(s)
1.
brivaracetam
2.
(2S)-2-((4R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide
3.
1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-
4.
2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide
5.
Briviact
6.
UCB 34714
7.
UCB-34714
8.
UCB34714
External Link(s)
MeSHC482793
PubChem Compound9837243
BindingDB50422531
ChEBI133013
CHEMBLCHEMBL607400
DrugBankDB05541
DrugCentral5068
IUPHAR/BPS Guide to PHARMACOLOGY9041
KEGGdr:D08879
Therapeutic Target DatabaseD0CT4D
ZINC3979899
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 34US FAERS
2SomnolenceFAERS: 16US FAERS
3DizzinessFAERS: 11US FAERS
4OverdoseFAERS: 8US FAERS
5Disease ProgressionFAERS: 6US FAERS
6AnxietyFAERS: 5US FAERS
7FatigueFAERS: 5US FAERS
8Intentional product misuseFAERS: 5US FAERS
9Product dose omissionFAERS: 5US FAERS
10NauseaFAERS: 4US FAERS
11VomitingFAERS: 4US FAERS
12AlopeciaFAERS: 3US FAERS
13Cardiac ArrestFAERS: 3US FAERS
14Feeling abnormalFAERS: 3US FAERS
15PancreatitisFAERS: 3US FAERS
16PregnancyFAERS: 3US FAERS
17SyncopeFAERS: 3US FAERS
18Unevaluable eventFAERS: 3US FAERS
19Accidental exposure to productFAERS: 2US FAERS
20AgitationFAERS: 2US FAERS
21AstheniaFAERS: 2US FAERS
22Change in seizure presentationFAERS: 2US FAERS
23Drug dose omissionFAERS: 2US FAERS
24Drug ineffective for unapproved indicationFAERS: 2US FAERS
25Euphoric moodFAERS: 2US FAERS
26HeadacheFAERS: 2US FAERS
27Intentional self-injuryFAERS: 2US FAERS
28Lip swellingFAERS: 2US FAERS
29Myocardial InfarctionFAERS: 2US FAERS
30Myoclonic EpilepsyFAERS: 2US FAERS
31MyoclonusFAERS: 2US FAERS
32No adverse eventFAERS: 2US FAERS
33PruritusFAERS: 2US FAERS
34Respiratory FailureFAERS: 2US FAERS
35Status EpilepticusFAERS: 2US FAERS
36Tongue bitingFAERS: 2US FAERS
37Ventricular FibrillationFAERS: 2US FAERS
38Accidental overdoseFAERS: 1US FAERS
39Acute kidney injuryFAERS: 1US FAERS
40Acute psychosisFAERS: 1US FAERS
41Adverse eventFAERS: 1US FAERS
42ArthralgiaFAERS: 1US FAERS
43AuraFAERS: 1US FAERS
44Bipolar DisorderFAERS: 1US FAERS
45BronchospasmFAERS: 1US FAERS
46Burning sensationFAERS: 1US FAERS
47Cardiovascular insufficiencyFAERS: 1US FAERS
48Cleft PalateFAERS: 1US FAERS
49DeliriumFAERS: 1US FAERS
50Depressed moodFAERS: 1US FAERS
51DisabilityFAERS: 1US FAERS
52Drug effect incompleteFAERS: 1US FAERS
53Dry skinFAERS: 1US FAERS
54DysgeusiaFAERS: 1US FAERS
55Emotional disorderFAERS: 1US FAERS
56EpilepsyFAERS: 119787095CTD
US FAERS
57ErythemaFAERS: 1US FAERS
58Gait inabilityFAERS: 1US FAERS
59Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
60GastroenteritisFAERS: 1US FAERS
61Head discomfortFAERS: 1US FAERS
62Hip surgeryFAERS: 1US FAERS
63HomicideFAERS: 1US FAERS
64HypersomniaFAERS: 1US FAERS
65Inappropriate affectFAERS: 1US FAERS
66InfectionFAERS: 1US FAERS
67Intracranial meningioma malignantFAERS: 1US FAERS
68LethargyFAERS: 1US FAERS
69Limb injuryFAERS: 1US FAERS
70Lower respiratory tract infectionFAERS: 1US FAERS
71MalaiseFAERS: 1US FAERS
72Maternal exposure before pregnancyFAERS: 1US FAERS
73Maternal exposure during pregnancyFAERS: 1US FAERS
74MenorrhagiaFAERS: 1US FAERS
75Mental FatigueFAERS: 1US FAERS
76Mood swingsFAERS: 1US FAERS
77Neck PainFAERS: 1US FAERS
78Oral mucosal erythemaFAERS: 1US FAERS
79PainFAERS: 1US FAERS
80PalpitationsFAERS: 1US FAERS
81Personality ChangeFAERS: 1US FAERS
82Preictal stateFAERS: 1US FAERS
83Prescribed underdoseFAERS: 1US FAERS
84Product complaintFAERS: 1US FAERS
85Product label issueFAERS: 1US FAERS
86Product packaging issueFAERS: 1US FAERS
87Product quality issueFAERS: 1US FAERS
88Respiratory DepressionFAERS: 1US FAERS
89RestlessnessFAERS: 1US FAERS
90SepsisFAERS: 1US FAERS
91Skin reactionFAERS: 1US FAERS
92Suicide attemptFAERS: 1US FAERS
93Tardive DyskinesiaFAERS: 1US FAERS
94TinnitusFAERS: 1US FAERS
95Transaminases increasedFAERS: 1US FAERS
96TremorFAERS: 1US FAERS
97Weight decreasedFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.